fr
Article scientifique
Français

Essais thérapeutiques dans la dystrophie musculaire de Duchenne: entre espoirs et désespoirs

Publié dansRevue médicale suisse, vol. 8, no. 329, p. 409-412
Date de publication2012
Résumé

Duchenne muscular dystrophy is an X-linked progressive muscle disease. Since the discovery of the dystrophin gene responsible for the condition, various therapeutic strategies have been elaborated. In this paper we introduce three of them, which are well into clinical trials. The first is based on the ability to read through premature stop codons, the second is based on the technique of exon skipping. Both strategies are examples of "personalized medicines", tailored for specific mutation types. The third approach is a pharmacological one, potentially useful for all Duchenne patients, regardless of their mutation type. These first clinical trials raise many questions for researchers as well as for patients and their families, some of which are discussed.

Mots-clés
  • Child
  • Genetic Therapy
  • Humans
  • Muscular Dystrophy, Duchenne/drug therapy/genetics
Citation (format ISO)
BLOETZER, Clemens, FLUSS, Joel Victor, JEANNET, Pierre-Yves. Essais thérapeutiques dans la dystrophie musculaire de Duchenne: entre espoirs et désespoirs. In: Revue médicale suisse, 2012, vol. 8, n° 329, p. 409–412.
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Identifiants
ISSN du journal1660-9379
468vues
0téléchargements

Informations techniques

Création08/10/2013 16:00:00
Première validation08/10/2013 16:00:00
Heure de mise à jour14/03/2023 20:38:29
Changement de statut14/03/2023 20:38:29
Dernière indexation16/01/2024 08:15:22
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack